Pharmafile Logo
Pharmafocus logo
Advanced Search
Teva image

Teva ‘to increase Mylan bid to $43bn’

July 7, 2015
Sales and Marketing M&A, MA, Mylan, Teva, generics

Israeli drugmaker Teva is considering whether to up its bid for US rival firm Mylan, with reports that it could …

News

Prescribing in England up 55% to £9bn over a decade

July 7, 2015
Manufacturing and Production, Sales and Marketing NHS, NHSIC, drugs, health and social care information centre, net ingredient cost, prescribing

The number of drugs issued in England continues to soar, according to the latest NHS figures which show prescribing in …

News

Biogen to build billion-dollar plant in Switzerland

July 7, 2015
Manufacturing and Production Alzherimer's disease, Biogen, Biogen IDEC, MS, Switzerland, manufacturing, multiple sclerosis

Biogen plans to open a $1 billion manufacturing facility in Switzerland, to help Europe deal with the future demand for …

News

Novo Nordisk pulls Tresiba in Germany after pricing row

July 6, 2015
Manufacturing and Production, Sales and Marketing Drug pricing, Germany, Novo Nordisk, Reimbursement, Tresiba, market access

Novo Nordisk has discontinued its distribution of once-daily basal insulin Tresiba after pricing talks with the German body that represents …

News
Bayer's Alexander Moscho

Working Life: Bayer UK & Ireland’s chief executive Alexander Moscho

July 6, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, Bayer

How did you find your way into your current role?I think it started when I was young and I was …

Feature

Adam Zaeske appointed as managing director of Takeda UK and Ireland

July 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adam Zaeske, Takeda

Japanese pharma firm Takeda has appointed Adam Zaeske as managing director of Takeda UK and Ireland.Zaeske has been with Takeda …

Appointment
AbbVie

NHS England approves AbbVie’s Duodopa for Parkinson’s disease

July 6, 2015
Sales and Marketing AbbVie, Duodopa, James Palmer, NHS England, PPRS, Parkinson's, Parkinson's disease, commissioning

AbbVie has been handed a boost by NHS England, who has approved the prescribing of its Parkinson’s disease treatment Duodopa …

News
Vertex logo

Vertex’s cystic fibrosis drug gets FDA approval

July 3, 2015
Research and Development, Sales and Marketing FDA, Orkambi, Vertex, cystic fibrosis, gene therapy

Vertex Pharmaceuticals cystic-fibrosis drug Orkambi, which could treat as many as 8,500 patients in the US, has been approved by …

News
Sanofi Paris HQ

Sanofi’s Toujeo approved in Japan

July 3, 2015
Manufacturing and Production, Sales and Marketing Japan, Lantus Lantus XR, Sanofi, diabetes, toujeo, type diabetes

The Ministry of Health, Labor and Welfare in Japan has given Sanofi a marketing authorisation for the diabetes drug the …

News
Xtandi

Astellas in ‘unacceptable’ Xtandi ABPI code breach

July 3, 2015
Medical Communications, Sales and Marketing ABPI Code, Astella, PMCPA, Xtandi

The industry code of conduct regulator has singled out Astellas for ‘particular censure’ for arranging a meeting for UK healthcare …

News

Prices to be printed on all prescribed NHS drugs over £20

July 2, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing Jeremy Hunt, NHS, UK, drugs, health secretary, medicines

NHS drugs costing more than £20 will, from next year, have the price and the words “funded by the UK …

News
BI building

Boehringer Ingelheim launches Spiolto for COPD

July 2, 2015
Sales and Marketing Boehringer Ingelheim, COPD, Europe, Spiolto, Spiriva, Striverdi

Boehringer Ingelheim is beginning a new push in lung disease across Europe after being approved by regulators in nine countries …

News
Drug R&D

Pharma outsourcing: CROs, CMOs and external collaboration

July 2, 2015
Manufacturing and Production, Research and Development CMOs, R&D, clinical trials, collaboration, cros, outsourcing

Thirty years ago pharma companies seemed to use external contractors as a sort of fire brigade, to be called in …

Feature
dr_goddard

Mission Therapeutics appoints Dr Colin Goddard to its board of directors

July 2, 2015
Research and Development Colin Goddard, Mission Therapeutics, appointments

MISSION Therapeutics, a drug discovery and development company today has appointed Dr Colin Goddard, former chief executive of OSI Pharmaceuticals, …

Appointment

Opdivo launched in the UK for skin cancer

July 2, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, EMA, Early Access to Medicines Scheme, MHRA, eams, melanoma, opdivo, skin cancer

Bristol-Myers Squibb has launched its cancer immunotherapy treatment Opdivo in the UK for patients with advanced skin cancer. Opdivo (nivolumab) …

News
michael_le_brocq

DJM Unlimited makes new director appointment

July 1, 2015
Medical Communications DJM Unlimited, Michael Le Brocq

UK and US based company DJM Unlimited has appointed Michael Le Brocq as board director. Le Brocq has 20 years’ …

Appointment
Professor Dame Sally Davies

Pfizer partners with NIHR to boosts UK R&D

July 1, 2015
Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies

Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …

News

Novartis launches ViaOpta Apple Watch app

July 1, 2015
Medical Communications Novartis, apple watch, apps, visual impairment, wearables

Novartis has launched new features of its ViaOpta app for use with the Apple Watch and other wearable devices. The …

News

Boehringer and Vitae Pharma drug fails in mid-stage trial

July 1, 2015
Research and Development BI, Boehringer, Boehringer Ingelheim, Vitae Pharmaceuticals, diabetes, type 2 diabetes

A pipeline diabetes drug co-developed by Vitae Pharma and German giants Boehringer Ingelheim has failed to show benefits in a …

News
FDA image

FDA sued over failure to disclose Sovaldi data

June 30, 2015
Sales and Marketing FDA, Gilead, hepatitis C, sofosbuvir, sovaldi

Two groups that campaign for wider access to medicines have filed a lawsuit against the FDA, in a bid to …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026